Welcome to LookChem.com Sign In|Join Free
  • or
Home > Reagent > 20830 > 

20830-75-5

Products Categories

Basic Information
CAS No.: 20830-75-5
Name: DIGOXIN
Article Data: 11
Molecular Structure:
Molecular Structure of 20830-75-5 (DIGOXIN)
Formula: C41H64O14
Molecular Weight: 780.951
Synonyms: Digitoxin,12b-hydroxy- (6Cl);12b-Hydroxydigitoxin;Cardigox;Cardiogoxin;Cardioxin;Cardixin;Cardoxin;Chloroformic digitalin;Coragoxine;Cordioxil;Davoxin;Digacin;Digomal;Digon;Digosin;Digoxin Nativelle;Digoxine;Dilanacin;Dynamos;Eudigox;Grexin;Homolle's digitalin;Lanacordin;Lanocardin;Lanorale;Lanoxicaps;Lanoxin;Lanoxin PG;Lenoxicaps;Lenoxin;Mapluxin;NSC 95100;Natigoxin;NeoDioxanin;Rougoxin;Stillacor;Toloxin;Vanoxin;
EINECS: 244-068-1
Density: 1.36 g/cm3
Melting Point: 248 °C
Boiling Point: 931.6 °C at 760 mmHg
Flash Point: 278.5 °C
Solubility: 46.08mg/L(room temperature)
Appearance: White cystalline pwder
Hazard Symbols: Moderately toxic.ToxicT, VeryT+
Risk Codes: 25-26/27/28
Safety: 22-36/37/39-45
Transport Information: UN 3462 6.1/PG 2
PSA: 203.06000
LogP: 2.21810
  • Display:default sort

    New supplier

  • Amadis Chemical offer CAS#20830-75-5;CAT#A814956

  • Casno:

    20830-75-5

    Amadis Chemical offer CAS#20830-75-5;CAT#A814956

    Min.Order: 10 Milligram

    FOB Price:  USD $ 0.0-0.0

    1.Professional synthesis laboratory and production base. 2.Strong synthesis team and service team. 3.Professional data management system. 4.We provide the professional test date and product information ,ex. HNMR ,CNMR,FNMR, HPLC/G

    Founded in 2011, Amadis Chemical Company Limited is an innovative manufacturer of chemical products and technical service providers. Our business includes sales, manufacture, and s

  • Amadis Chemical Co., Ltd.

     China (Mainland)  |  Contact Details

    Business Type:Lab/Research institutions

    Tel:86-571-89925085

    Address:Watts Cosine.No.166.Xiangmao Road.

       Inquiry Now

  • Digoxin

  • Casno:

    20830-75-5

    Digoxin

    Min.Order: 1 Gram

    FOB Price:  USD $ 500.0-500.0

    Digoxin Application:815713

    PureChems is dedicated to bring high quality and cost effective chemical products and services to our clients. PureChems can provide high purity Natural Products, Research Chemical

  • Pure Chemistry Scientific Inc.

    United States  |  Contact Details

    Business Type:Trading Company

    Tel:+1-857-366-7588

    Address:14905 SW freeway street #232, Sugarland, TX 77478, USA

       Inquiry Now

  • Total:2 Page 1 of 1 1
Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 20830-75-5

Consensus Reports

EPA Extremely Hazardous Substances List. Reported in EPA TSCA Inventory. EPA Genetic Toxicology Program.

Specification

The Digoxin with CAS registry number of 20830-75-5 is also known as Cardiogoxin. The IUPAC name is 3-[(3S,5R,8R,9S,10S,12R,13S,14S,17R)-3-[(2R,4S,5S,6R)-5-[(2S,4S,5S,6R)-5-[(2S,4S,5S,6R)-4,5-Dihydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-6-methyloxan-2-yl]oxy-12,14-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one. It belongs to product categories of Organics; Biochemistry; Glycosides; Steroidglycosides; Steroids; Sugars; Trisaccharides; Intermediates & Fine Chemicals; Pharmaceuticals; ATPase. Its EINECS registry number is 244-068-1. In addition, the formula is C41H64O14 and the molecular weight is 780.94. This chemical is a white cystalline pwder and should be sealed in cool and dry place away from oxides.

Physical properties about Digoxin are: (1)ACD/LogP: 0.85; (2)# of Rule of 5 Violations: 3; (3)ACD/LogD (pH 5.5): 0.85; (4)ACD/LogD (pH 7.4): 0.85; (5)ACD/BCF (pH 5.5): 2.61; (6)ACD/BCF (pH 7.4): 2.61; (7)ACD/KOC (pH 5.5): 69.21; (8)ACD/KOC (pH 7.4): 69.21; (9)#H bond acceptors: 14; (10)#H bond donors: 6; (11)#Freely Rotating Bonds: 13; (12)Index of Refraction: 1.602; (13)Molar Refractivity: 196.38 cm3; (14)Molar Volume: 572.3 cm3; (15)Surface Tension: 64.5 dyne/cm; (16)Density: 1.36 g/cm3; (17)Flash Point: 278.5 °C; (18)Enthalpy of Vaporization: 153.77 kJ/mol; (19)Boiling Point: 931.6 °C at 760 mmHg.

Preparation of Digoxin: it is extracted from the foxglove plant, digitalis lanata. After fermentation of dry leaves, reactant is extracted by ethanol, chloroform and recrystallized by 70% ethanol to obtain the product.

Uses of Digoxin: it is used to produce 3b,14-dihydroxy-12-oxo-5b,14b-card-20(22)-enolid. The reaction occurs with reagent CrO3 and solvent dimethylformamide for 30 hours. The yield is about 60%. Besides, it is used as cholesterol reagent, tonic and also used in biochemical research.

Digoxin is used to produce 3b,14-dihydroxy-12-oxo-5b,14b-card-20(22)-enolid.

When you are using this chemical, please be cautious about it. As a chemical, it is very toxic by inhalation, in contact with skin and if swallowed. During using it, wear suitable protective clothing, gloves and eye/face protection. Do not breathe dust. In case of accident or if you feel unwell seek medical advice immediately.

You can still convert the following datas into molecular structure:
1. Canonical SMILES: CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O
2. Isomeric SMILES: C[C@@H]1[C@H]([C@H](C[C@@H](O1)O[C@@H]2[C@H](O[C@H](C[C@@H]2O)O[C@@H]3[C@H](O[C@H](C[C@@H]3O)O[C@H]4CC[C@]5([C@@H](C4)CC[C@@H]6[C@@H]5C[C@H]([C@]7([C@@]6(CC[C@@H]7C8=CC(=O)OC8)O)C)O)C)C)C)O)O
3. InChI: InChI=1S/C41H64O14/c1-19-36(47)28(42)15-34(50-19)54-38-21(3)52-35(17-30(38)44)55-37-20(2)51-33(16-29(37)43)53-24-8-10-39(4)23(13-24)6-7-26-27(39)14-31(45)40(5)25(9-11-41(26,40)48)22-12-32(46)49-18-22/h12,19-21,23-31,33-38,42-45,47-48H,6-11,13-18H2,1-5H3/t19-,20-,21-,23-,24+,25-,26-,27+,28+,29+,30+,31-,33+,34+,35+,36-,37-,38-,39+,40+,41+/m1/s1
4. InChIKey: LTMHDMANZUZIPE-PUGKRICDSA-N

The toxicity data is as follows: 

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
cat LD50 oral 200ug/kg (0.2mg/kg)   Archives Internationales de Pharmacodynamie et de Therapie. Vol. 159, Pg. 1, 1966.
cat LDLo intraduodenal 441ug/kg (0.441mg/kg)   Arzneimittel-Forschung. Drug Research. Vol. 20, Pg. 1765, 1970.
cat LDLo intravenous 159ug/kg (0.159mg/kg)   Arzneimittel-Forschung. Drug Research. Vol. 19, Pg. 657, 1969.
cat LDLo parenteral 1470ug/kg (1.47mg/kg)   Acta Poloniae Pharmaceutica. For English translation, see APPFAR. Vol. 34, Pg. 431, 1977.
child TDLo oral 54ug/kg (0.054mg/kg) CARDIAC: PULSE RATE American Journal of Emergency Medicine. Vol. 4, Pg. 364, 1986.
child TDLo oral 127ug/kg (0.127mg/kg) CARDIAC: PULSE RATE American Family Physician. Vol. 34(1), Pg. 137, 1986.
dog LDLo intravenous 200ug/kg (0.2mg/kg)   Comptes Rendus des Seances de la Societe de Biologie et de Ses Filiales. Vol. 109, Pg. 279, 1932.
dog LDLo oral 300ug/kg (0.3mg/kg)   Comptes Rendus des Seances de la Societe de Biologie et de Ses Filiales. Vol. 109, Pg. 279, 1932.
frog LD50 subcutaneous 2240ng/kg (0.00224mg/kg)   Russian Pharmacology and Toxicology Vol. 53, Pg. 171, 1990.
frog LDLo parenteral 1mg/kg (1mg/kg)   Chemical and Pharmaceutical Bulletin. Vol. 11, Pg. 613, 1963.
guinea pig LD50 intraduodenal 3200ug/kg (3.2mg/kg) CARDIAC: CARDIOMYOPATHY INCLUDING INFARCTION

CARDIAC: ARRHYTHMIAS (INCLUDING CHANGES IN CONDUCTION)
Arzneimittel-Forschung. Drug Research. Vol. 21, Pg. 225, 1971.
guinea pig LD50 intramuscular 630ug/kg (0.63mg/kg)   Drugs in Japan Vol. 6, Pg. 316, 1982.
guinea pig LD50 intraperitoneal 800ug/kg (0.8mg/kg)   Oyo Yakuri. Pharmacometrics. Vol. 7, Pg. 373, 1973.
guinea pig LD50 oral 3500ug/kg (3.5mg/kg)   Archives Internationales de Pharmacodynamie et de Therapie. Vol. 159, Pg. 1, 1966.
guinea pig LD50 subcutaneous 600ug/kg (0.6mg/kg) CARDIAC: ARRHYTHMIAS (INCLUDING CHANGES IN CONDUCTION) Journal of Pharmacy and Pharmacology. Vol. 35, Pg. 580, 1983.
guinea pig LDLo intravenous 468ug/kg (0.468mg/kg) BRAIN AND COVERINGS: RECORDINGS FROM SPECIFIC AREAS OF CNS

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

CARDIAC: OTHER CHANGES
Archives Internationales de Pharmacodynamie et de Therapie. Vol. 153, Pg. 436, 1965.
infant LDLo intravenous 200ug/kg (0.2mg/kg) CARDIAC: PULSE RATE Pediatrics. Vol. 77, Pg. 848, 1986.
infant TDLo intravenous 50ug/kg (0.05mg/kg) CARDIAC: PULSE RATE American Family Physician. Vol. 34(1), Pg. 137, 1986.
man TDLo oral 75ug/kg (0.075mg/kg) CARDIAC: EKG CHANGES NOT DIAGNOSTIC OF ABOVE

CARDIAC: PULSE RATE INCREASE WITHOUT FALL IN BP
American Journal of Emergency Medicine. Vol. 6, Pg. 465, 1988.
man TDLo oral 333ug/kg (0.333mg/kg) SENSE ORGANS AND SPECIAL SENSES: VISUAL FIELD CHANGES: EYE

CARDIAC: PULSE RATE
British Medical Journal. Vol. 287, Pg. 392, 1983.
man TDLo unreported 13ug/kg/4D-I (0.013mg/kg) BEHAVIORAL: CHANGES IN PSYCHOPHYSIOLOGICAL TESTS

VASCULAR: OTHER CHANGES

LUNGS, THORAX, OR RESPIRATION: DYSPNEA
American Heart Journal. Vol. 106, Pg. 419, 1983.
mouse LD50 intracrebral 124ug/kg (0.124mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD Pharmacological Research Communications. Vol. 6, Pg. 417, 1974.
mouse LD50 intraperitoneal 3964ug/kg (3.964mg/kg)   Chemotherapy Vol. 16, Pg. 371, 1971.
mouse LD50 intravenous 7670ug/kg (7.67mg/kg)   Pharmacological Research Communications. Vol. 6, Pg. 417, 1974.
mouse LD50 oral 17780ug/kg (17.78mg/kg) BRAIN AND COVERINGS: RECORDINGS FROM SPECIFIC AREAS OF CNS

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

CARDIAC: OTHER CHANGES
Archives Internationales de Pharmacodynamie et de Therapie. Vol. 153, Pg. 436, 1965.
mouse LD50 subcutaneous 8150ng/kg (0.00815mg/kg)   Russian Pharmacology and Toxicology Vol. 53, Pg. 171, 1990.
mouse LDLo parenteral 2947ug/kg (2.947mg/kg)   Shang-hai I Hsueh. Vol. 4(2), Pg. 32, 1981.
pig LDLo intraduodenal 1580ug/kg (1.58mg/kg)   Arzneimittel-Forschung. Drug Research. Vol. 20, Pg. 229, 1970.
pig LDLo intravenous 230ug/kg (0.23mg/kg)   Arzneimittel-Forschung. Drug Research. Vol. 20, Pg. 229, 1970.
pigeon LDLo intravenous 337ug/kg (0.337mg/kg) CARDIAC: ARRHYTHMIAS (INCLUDING CHANGES IN CONDUCTION)

CARDIAC: CHANGE IN RATE

GASTROINTESTINAL: NAUSEA OR VOMITING
Archives Internationales de Pharmacodynamie et de Therapie. Vol. 126, Pg. 412, 1960.
pigeon LDLo parenteral 450ug/kg (0.45mg/kg)   Chemical and Pharmaceutical Bulletin. Vol. 11, Pg. 613, 1963.
rabbit LD50 intravenous 3560ug/kg (3.56mg/kg)   Drugs in Japan Vol. 6, Pg. 316, 1982.
rat LD50 intraperitoneal 4mg/kg (4mg/kg)   Journal of Drug Research. Vol. 17, Pg. 247, 1987.
rat LD50 intravenous 25mg/kg (25mg/kg)   Archives Internationales de Pharmacodynamie et de Therapie. Vol. 155, Pg. 165, 1965.
rat LD50 oral 28270ug/kg (28.27mg/kg)   Archives Internationales de Pharmacodynamie et de Therapie. Vol. 164, Pg. 47, 1966.
rat LD50 subcutaneous 8900ng/kg (0.0089mg/kg)   Russian Pharmacology and Toxicology Vol. 53, Pg. 171, 1990.
rat LDLo rectal 5mg/kg (5mg/kg) CARDIAC: PULSE RATE Planta Medica. Vol. 25, Pg. 88, 1974.
women TDLo oral 100ug/kg (0.1mg/kg) BEHAVIORAL: ANOREXIA (HUMAN

CARDIAC: ARRHYTHMIAS (INCLUDING CHANGES IN CONDUCTION)

GASTROINTESTINAL: NAUSEA OR VOMITING
New Zealand Medical Journal. Vol. 84, Pg. 443, 1976.
women TDLo oral 165ug/kg/33D- (0.165mg/kg) BEHAVIORAL: GENERAL ANESTHETIC

BEHAVIORAL: MUSCLE CONTRACTION OR SPASTICITY)
British Medical Journal. Vol. 296, Pg. 1262, 1988.
women TDLo oral 500ug/kg (0.5mg/kg) CARDIAC: EKG CHANGES NOT DIAGNOSTIC OF ABOVE

CARDIAC: PULSE RATE INCREASE WITHOUT FALL IN BP

GASTROINTESTINAL: NAUSEA OR VOMITING
Clinical Toxicology. Vol. 15, Pg. 437, 1979.